Covisint Stock Soars After IPOShares in Detroit's newest tech stock soared Thursday, the first day of their trading on the Nasdaq Global Select Market.
UM Startup In California Raises $82M In IPOOncoMed Pharmaceuticals, a California-based company started at the University of Michigan in 2004 with Taubman Scholar Max Wicha, M.D., as co-founder, raised $82 million in an initial public offering that ended last week.
Esperion Stock Interest Strong, Underwriters’ Over-Allotment Option ExercisedEsperion Therapeutics Inc. (Nasdaq: ESPR), the Plymouth-based developer of new drugs to lower cholesterol levels in the blood, announced that the underwriters of its recently completed initial public offering have exercised in full their option to purchase an additional 750,000 shares of common stock from Esperion to cover over-allotments.
Esperion Therapeutics Going Public (Again) At $14 A Share
Compuware's Covisint Files IPO Of Up To $100MCompuware Corp. (Nasdaq:CPWR) plans to sell up to $100 million worth of stock in its Covisint subsidiary.
Compuware Takes Next Step For Covisint Stock SaleThe Detroit-based software and IT services provider Compuware Corp. (Nasdaq: CPWR) said Friday it submitted a draft registration for a stock sale in its Covisint secure communication portal subsidiary.
GM Confirms Increase In Size Of Public Offering
Are There Red Flags With GM's Initial Stock Offering?
Report: China's Largest Automaker To Invest In GM
GM Begins Roadshow To Pitch Stock Offering
WSJ: GM Plans IPO "Road Show"
GM Clarifies Chairman's Comments On IPO